FREE Transcranial direct current stimulation (tDCS) for Parkinson's on Amazon

-

Comments

Post a Comment

Popular posts from this blog

The surprising benefits of celery stalks (celery)

-
Image
The surprising benefits of celery stalks (celery) Celery is the trade name, derived from the Spanish language, for the sweet celery strain.   It is very beneficial to the health, having significant nutritional properties.   It has a large proportion of water (95%) and offers very few   calories. It contains vitamins A, B1, B2, B6, B9, C, E and K, minerals such as sodium, potassium, calcium, zinc, magnesium, iron, copper, sulfur, phosphorus and silicon, fibers and essential oils. Due to the 8  anticancer  compounds it contains, it can be both effective in preventing  cancer , accelerating the development of white  blood cells  that destroy  cancer cells . In the strain of celery, there is a compound called coumarin that can prevent the formation and development of stomach and colon cancer. Helps eliminate  toxins from the body  faster, improving  kidney  function.   If you are used to making  kidney stones , the celery strain stops their formation. Its consumptio
Read more

Cough syrup drug being trialed as Parkinson’s treatment

-
Image
Summary:  Ambroxol, a medication approved to treat coughs, may slow the progression of Parkinson’s disease. The medication is able to effectively cross the blood-brain barrier and increases levels of GCase in patients’ brains. Ambroxol also appears to reduce Parkinson’s-related alpha-synuclein levels. Source:  UCL Ambroxol, a medication originally designed to clear phlegm and ease coughing for people with respiratory diseases such as bronchitis, is being tested to see if it can slow down the progression of Parkinson’s disease by keeping cells healthier for longer. A research team led by Professor Tony Schapira (UCL Queen Square Institute of Neurology) reported in January that ambroxol was safe and well-tolerated in 17 study participants with Parkinson’s disease. According to the findings published in  JAMA Neurology,  the drug also effectively crossed the blood-brain barrier and increased levels of the glucocerebrosidase (GCase) protein in the participants’ brain cells.
Read more